Minerva Neurosciences Stock Story
| NERV Stock | USD 2.52 0.01 0.40% |
Slightly above 67% of Minerva Neurosciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Minerva Neurosciences suggests that many traders are alarmed. Minerva Neurosciences' investor sentiment overview provides quick insight into current market opportunities from investing in Minerva Neurosciences. The current market sentiment, together with Minerva Neurosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Minerva Neurosciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Minerva Neurosciences stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Minerva daily returns and investor perception about the current price of Minerva Neurosciences as well as its diversification or hedging effects on your existing portfolios.
Minerva |
Requested story not found. it has been either deleted or moved. View all stories for Minerva Neurosciences.
Minerva Neurosciences Latest Timeline
Minerva Neurosciences is listed for 2.52. About 22.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 4.61. Minerva Neurosciences had not issued any dividends in recent years. The entity had 1:8 split on the 21st of June 2022.Check out Minerva Neurosciences Hype Analysis, Minerva Neurosciences Correlation and Minerva Neurosciences Performance. For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Minerva Stock analysis
When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |
Is Minerva Neurosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Minerva Neurosciences. If investors know Minerva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Minerva Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.61) | Return On Assets (0.26) | Return On Equity (6.75) |
The market value of Minerva Neurosciences is measured differently than its book value, which is the value of Minerva that is recorded on the company's balance sheet. Investors also form their own opinion of Minerva Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is Minerva Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Minerva Neurosciences' market value can be influenced by many factors that don't directly affect Minerva Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Minerva Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Minerva Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Minerva Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.